Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy
暂无分享,去创建一个
[1] Edward J Oakeley,et al. Interferon signaling and treatment outcome in chronic hepatitis C , 2008, Proceedings of the National Academy of Sciences.
[2] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[3] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[4] Luigi Naldini,et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state , 2007, Nature Biotechnology.
[5] Stefano Volinia,et al. Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.
[6] T. Asselah,et al. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C , 2007, Gut.
[7] Chris Sander,et al. Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.
[8] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[9] Limin Chen,et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. , 2005, Gastroenterology.
[10] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[11] Kenneth Koury,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .